prednisone has been researched along with Deficiency, Factor 5 in 7 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe factor V deficiency (< 1%) caused by an antibody to factor V (26 BU/ml) was found." | 1.29 | Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression. ( Aspöck, G; Derfler, K; Hörl, W; Jäger, U; Kapiotis, S; Knöbl, P; Lechner, K; Tribl, B, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, Y | 1 |
| Nakazato, T | 1 |
| Ito, C | 1 |
| Masuda, K | 1 |
| Osada, Y | 1 |
| Aisa, Y | 1 |
| Mori, T | 1 |
| Mouton, C | 1 |
| Leroux, L | 1 |
| Bonnet, G | 1 |
| Seguy, B | 1 |
| Lafargue, A | 1 |
| Baulier, G | 1 |
| Castet, S | 1 |
| Fiore, M | 1 |
| Cui, QY | 1 |
| Shen, HS | 1 |
| Wu, TQ | 1 |
| Chen, HF | 1 |
| Yu, ZQ | 1 |
| Wang, ZY | 1 |
| Tribl, B | 1 |
| Knöbl, P | 1 |
| Derfler, K | 1 |
| Kapiotis, S | 1 |
| Aspöck, G | 1 |
| Jäger, U | 1 |
| Hörl, W | 1 |
| Lechner, K | 1 |
| Monfort-Gouraud, M | 1 |
| Leroy, B | 1 |
| Favier, R | 1 |
| Bensman, A | 1 |
| Fu, YX | 1 |
| Kaufman, R | 1 |
| Rudolph, AE | 1 |
| Collum, SE | 1 |
| Blinder, MA | 1 |
| Carter, CJ | 1 |
| Devine, DV | 1 |
| Rogers, PC | 1 |
| Wadsworth, LD | 1 |
7 other studies available for prednisone and Deficiency, Factor 5
| Article | Year |
|---|---|
A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
Topics: Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Azacitidine; Earl | 2018 |
Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Aortic Valve Stenosis; Atrial Fibrillation | 2019 |
Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Blood Coagulation Tests; Brain Stem; Ceftazidime; F | 2015 |
Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression.
Topics: Aged; Blood Coagulation Tests; Blood Component Transfusion; Combined Modality Therapy; Cyclophospham | 1995 |
[Transient correction of partial congenital factor V deficiency in nephrotic syndrome].
Topics: Child, Preschool; Factor V Deficiency; Female; Humans; IgA Vasculitis; Methylprednisolone; Nephrotic | 1995 |
Multimodality therapy of an acquired factor V inhibitor.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Combined Modality Therapy; Cyclophosphamide; Factor V; Fa | 1996 |
Steroid-responsive type II anti-factor VIII:C autoantibody in a nonhemophiliac child.
Topics: Autoantibodies; Autoimmune Diseases; Child; Factor V Deficiency; Factor VIII; Female; Hematuria; Hum | 1990 |